Funds and ETFs REYON Pharmaceutical Co., Ltd.

Equities

A102460

KR7102460003

Pharmaceuticals

End-of-day quote Korea S.E. 18:00:00 2024-05-08 EDT 5-day change 1st Jan Change
14,200 KRW +0.07% Intraday chart for REYON Pharmaceutical Co., Ltd. +3.05% -14.15%
REYON PHARMACEUTICAL Co. Ltd. is a Korea-based company engaged in the provision of pharmaceutical products. The Company’s products consist of remedies for circulatory systems, endocrine systems, digestive systems, respiratory systems, urinary systems and nervous systems, as well as eye drops, antibiotics, fever reducers, painkillers, anti-inflammatory drugs, antihistaminic agents, enzyme preparations, arthritis remedies, antitumor drugs and topical anesthetics, among others. It also produces pharmaceutical raw materials, such as arbekacin sulfate, alibendol, carvedilol, enocitabine, gemcitabine, glimepiride, lamotrigine, meloxicam, oxaliplatin, pioglitazone hydrochloride, ramipril, streptokinase, tacrolimus, thioctic acid, teicoplanin, voglibose and others.
More about the company
  1. Stock Market
  2. Equities
  3. A102460 Stock
  4. Funds and ETFs REYON Pharmaceutical Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW